Smoking and Cardiovascular Diseases

Cigarette Smoke Toxicity: Linking Individual Chemicals to Human Diseases

Volumn , Issue , 2011, Pages 121-144

  Bernhard, David ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Anti hypertensive drugs; Atherosclerosis; Hypercholesterolemia; N acetylcysteine; Nicotine; Oxidative damage; Plaque formation; Risk factors; Thrombogenesis

Indexed keywords

EID: 84882838724     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527635320.ch7     Document Type: Chapter

References (113)

1. World Health Organization (2004) Global Cardiovascular Infobase. http://www.cvdinfobase.ca (accessed 9 December 2010).
2. World Health Organization (2009) Cardiovascular diseases (CVDs), Fact Sheet No. 317. WHO, Geneva.
3. Hanke, H., Lenz, C., and Finking, G. (2001) The discovery of the pathophysiological aspects of atherosclerosis-a review. Acta Chir. Belg., 101, 162-169.
4. Knoflach, M., Kiechl, S., Kind, M., Said, M., Sief, R., Gisinger, M., et al. (2003) Cardiovascular risk factors and atherosclerosis in young males: ARMY study (Atherosclerosis Risk - Factors in Male Youngsters). Circulation, 108, 1064-1069.
5. Ross, R. (1976) Atherosclerosis: the role of endothelial injury, smooth muscle proliferation and platelet factors. Triangle, 15, 45-51.
6. Ross, R., Glomset, J., and Harker, L. (1977) Response to injury and atherogenesis. Am. J. Pathol., 86, 675-684.
7. Madamanchi, N.R., Vendrov, A., and Runge, M.S. (2005) Oxidative stress and vascular disease. Arterioscler. Thromb. Vasc. Biol., 25, 29-38.
8. Robbesyn, F., Salvayre, R., and Negre - Salvayre, A. (2004) Dual role of oxidized LDL on the NF - kappaB signaling pathway. Free Radic. Res., 38, 541-551.
9. Wick, G., Knoflach, M., and Xu, Q. (2004) Autoimmune and inflammatory mechanisms in atherosclerosis. Annu. Rev. Immunol., 22, 361-403.
10. Michiels, C. (2003) Endothelial cell functions. J. Cell. Physiol., 196, 430-443.
11. Langer, H.F. and Chavakis, T. (2009) Leukocyte - endothelial interactions in inflammation. J. Cell. Mol. Med., 13, 1211-1220.
12. Mestas, J. and Ley, K. (2008) Monocyte -endothelial cell interactions in the development of atherosclerosis. Trends Cardiovasc. Med., 18, 228-232.
13. Webb, N.R. and Moore, K.J. (2007) Macrophage - derived foam cells in atherosclerosis: lessons from murine models and implications for therapy. Curr. Drug Targets, 8, 1249-1263.
14. Simionescu, M. (2007) Implications of early structural - functional changes in the endothelium for vascular disease. Arterioscler. Thromb. Vasc. Biol., 27, 266-274.
15. Cullen, P., Rauterberg, J., and Lorkowski, S. (2005) The pathogenesis of atherosclerosis. Handb. Exp. Pharmacol., 3-70.
16. Badimon, J.J., Ibanez, B., and Cimmino, G. (2009) Genesis and dynamics of atherosclerotic lesions: implications for early detection. Cerebrovasc. Dis., 27 (Suppl. 1), 38-47.
17. Ross, R. (1999) Atherosclerosis-an inflammatory disease. N. Engl. J. Med., 340, 115-126.
18. Fishbein, M.C. (2010) The vulnerable and unstable atherosclerotic plaque. Cardiovasc. Pathol., 19, 6-11.
19. Utermann, G., Vogelberg, K.H., Steinmetz, A., Schoenborn, W., Pruin, N., Jaeschke, M., et al. (1979) Polymorphism of apolipoprotein E. II. Genetics of hyperlipoproteinemia type III. Clin. Genet., 15, 37-62.
20. Matchar, D.B., McCrory, D.C., Orlando, L.A., Patel, M.R., Patel, U.D., Patwardhan, M.B., et al. (2008) Systematic review: comparative effectiveness of angiotensin - converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertension. Ann. Intern. Med., 148, 16-29.
21. Delahoy, P.J., Magliano, D.J., Webb, K., Grobler, M., and Liew, D. (2009) The relationship between reduction in low - density lipoprotein cholesterol by statins and reduction in risk of cardiovascular outcomes: an updated meta - analysis. C lin. Ther., 31, 236-244.
22. Ezzati, M., Henley, S.J., Thun, M.J., and Lopez, A.D. (2005) Role of smoking in global and regional cardiovascular mortality. C irculation, 112, 489-497.
23. World Health Organization (2004) Tobacco Free Initiative. http://who.int/ tobacco/en (accessed 9 December 2010).
24. Teo, K.K., Ounpuu, S., Hawken, S., Pandey, M.R., Valentin, V., Hunt, D., et al. (2006) Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case - control study. Lancet, 368, 647-658.
25. McVary, K.T., Carrier, S., and Wessells, H. (2001) Smoking and erectile dysfunction: evidence based analysis. J. Urol., 166, 1624-1632.
26. Burns, D.M. (2003) Epidemiology of smoking - induced cardiovascular disease. Prog. Cardiovasc. Dis., 46, 11-29.
27. U.S. Department of Health and Human Services (2006) T he Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Coordinating Center for Health Promotion, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Atlanta, GA.
28. Bernhard, D., Moser, C., Backovic, A., and Wick, G. (2007) Cigarette smoke-an aging accelerator? Exp. Gerontol., 42, 160-165.
29. Bernhard, D., Rossmann, A., and Wick, G. (2005) Metals in cigarette smoke. IUBMB Life, 57, 805-809.
30. Bernhard, D. and Wang, X.L. (2007) Smoking, oxidative stress and cardiovascular diseases-do anti -oxidative therapies fail? Curr. Med. Chem., 14, 1703-1712.
31. Pryor, W.A. and Stone, K. (1993) Oxidants in cigarette smoke. Radicals, hydrogen peroxide, peroxynitrate, and peroxynitrite. A nn. N. Y. Acad. Sci., 686, 12-27.
32. Pryor, W.A., Stone, K., Zang, L.Y., and Bermudez, E. (1998) Fractionation of aqueous cigarette tar extracts: fractions that contain the tar radical cause DNA damage. Chem. Res. Toxicol., 11, 441-448.
33. Heitzer, T., Yla - Herttuala, S., Luoma, J., Kurz, S., Munzel, T., Just, H., et al. (1996) Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia. Role of oxidized LDL. Circulation, 93, 1346-1353.
34. Shashkin, P., Dragulev, B., and Ley, K. (2005) Macrophage differentiation to foam cells. Curr. Pharm. Des., 11, 3061-3072.
35. Doran, A.C., Meller, N., and McNamara, C.A. (2008) Role of smooth muscle cells in the initiation and early progression of atherosclerosis. Arterioscler. Thromb. Vasc. Biol., 28, 812-819.
36. Bernhard, D., Pfister, G., Huck, C.W., Kind, M., Salvenmoser, W., Bonn, G.K., et al. (2003) Disruption of vascular endothelial homeostasis by tobacco smoke: impact on atherosclerosis. FASEB J., 17, 2302-2304.
37. Tagawa, Y., Hiramatsu, N., Kasai, A., Hayakawa, K., Okamura, M., Yao, J., et al. (2008) Induction of apoptosis by cigarette smoke via ROS - dependent endoplasmic reticulum stress and CCAAT/enhancer - binding protein -homologous protein (CHOP). Free Radic. Biol. Med., 45, 50-59.
38. Basu, S., Binder, R.J., Suto, R., Anderson, K.M., and Srivastava, P.K. (2000) Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF - kappa B pathway. Int. Immunol., 12, 1539-1546.
39. Cocco, R.E. and Ucker, D.S. (2001) Distinct modes of macrophage recognition for apoptotic and necrotic cells are not specified exclusively by phosphatidylserine exposure. Mol. Biol. Cell, 12, 919-930.
40. Ota, Y., Kugiyama, K., Sugiyama, S., Ohgushi, M., Matsumura, T., Doi, H., et al. (1997) Impairment of endothelium - dependent relaxation of rabbit aortas by cigarette smoke extract-role of free radicals and attenuation by captopril. Atherosclerosis, 131, 195-202.
41. Neunteufl, T., Heher, S., Kostner, K., Mitulovic, G., Lehr, S., Khoschsorur, G., et al. (2002) Contribution of nicotine to acute endothelial dysfunction in long - term smokers. J. Am. Coll. Cardiol., 39, 251-256.
42. Neunteufl, T., Priglinger, U., Heher, S., Zehetgruber, M., Soregi, G., Lehr, S.,et al. (2000) Effects of vitamin E on chronic and acute endothelial dysfunction in smokers. J. Am. Coll. Cardiol., 35, 277-283.
43. Tsuchiya, M., Asada, A., Kasahara, E., Sato, E.F., Shindo, M., and Inoue, M. (2002) Smoking a single cigarette rapidly reduces combined concentrations of nitrate and nitrite and concentrations of antioxidants in plasma. Circulation, 105, 1155-1157.
44. Pittilo, R.M. (2000) Cigarette smoking, endothelial injury and cardiovascular disease. Int. J. Exp. Pathol., 81, 219-230.
45. Bernhard, D., Huck, C.W., Jakschitz, T., Pfister, G., Henderson, B., Bonn, G.K., et al. (2004) Development and evaluation of an in vitro model for the analysis of cigarette smoke effects on cultured cells and tissues. J. Pharmacol. Toxicol. Methods, 50, 45-51.
46. Bernhard, D., Csordas, A., Henderson, B., Rossmann, A., Kind, M., and Wick, G. (2005) Cigarette smoke metal -catalyzed protein oxidation leads to vascular endothelial cell contraction by depolymerization of microtubules. FASEB J., 19, 1096-1107.
47. Davis, J.W., Shelton, L., Eigenberg, D.A., and Hignite, C.E. (1987) Lack of effect of aspirin on cigarette smoke -induced increase in circulating endothelial cells. Haemostasis, 17, 66-69.
48. Henderson, B., Csordas, A., Backovic, A., Kind, M., Bernhard, D., and Wick, G. (2008) Cigarette smoke is an endothelial stressor and leads to cell cycle arrest. Atherosclerosis, 201, 298-305.
49. Chen, H.W., Lii, C.K., Ku, H.J., and Wang, T.S. (2009) Cigarette smoke extract induces expression of cell adhesion molecules in HUVEC via actin filament reorganization. Environ. Mol. Mutagen., 50, 96-104.
50. Wick, G., Knoflach, M., Kind, M., Henderson, B., and Bernhard, D. (2004) Heat shock proteins and stress in atherosclerosis. Autoimmun. Rev., 3 (Suppl 1), S30-S31.
51. Habich, C., Baumgart, K., Kolb, H., and Burkart, V. (2002) The receptor for heat shock protein 60 on macrophages is saturable, specific, and distinct from receptors for other heat shock proteins. J. Immunol., 168, 569-576.
52. Burke, A. and Fitzgerald, G.A. (2003) Oxidative stress and smoking - induced vascular injury. Prog. Cardiovasc. Dis., 46, 79-90.
53. Blache, D. (1995) Involvement of hydrogen and lipid peroxides in acute tobacco smoking - induced platelet hyperactivity. Am. J. Physiol., 268, H679-H685.
54. Ichiki, K., Ikeda, H., Haramaki, N., Ueno, T., and Imaizumi, T. (1996) Long - term smoking impairs platelet -derived nitric oxide release. Circulation, 94, 3109-3114.
55. Sawada, M., Kishi, Y., Numano, F., and Isobe, M. (2002) Smokers lack morning increase in platelet sensitivity to nitric oxide. J. Cardiovasc. Pharmacol., 40, 571-576.
56. Newby, D.E., Wright, R.A., Labinjoh, C., Ludlam, C.A., Fox, K.A., Boon, N.A., et al. (1999) Endothelial dysfunction, impaired endogenous fibrinolysis, and cigarette smoking: a mechanism for arterial thrombosis and myocardial infarction. Circulation, 99, 1411-1415.
57. Tuut, M. and Hense, H.W. (2001) Smoking, other risk factors and fibrinogen levels. evidence of effect modification. Ann. Epidemiol., 11, 232-238.
58. Shebuski, R.J. and Kilgore, K.S. (2002) Role of inflammatory mediators in thrombogenesis. J. Pharmacol. Exp. Ther., 300, 729-735.
59. McGill, H.C., Jr, McMahan, C.A., Zieske, A.W., Tracy, R.E., Malcom, G.T., Herderick, E.E., et al. (2000) Association of coronary heart disease risk factors with microscopic qualities of coronary atherosclerosis in youth. Circulation, 102, 374-379.
60. Libby, P. (2001) Current concepts of the pathogenesis of the acute coronary syndromes. Circulation, 104, 365-372.
61. Libby, P. (1995) Molecular bases of the acute coronary syndromes. Circulation, 91, 2844-2850.
62. Rocnik, E.F., Chan, B.M., and Pickering, J.G. (1998) Evidence for a role of collagen synthesis in arterialsmooth muscle cell migration. J. Clin. Invest., 101, 1889-1898.
63. Anderson, H.V. (1993) Restenosis after coronary angioplasty. Dis. Mon, 39, 613-670.
64. Kennon, S., Suliman, A., MacCallum, P.K., Ranjadayalan, K., Wilkinson, P., and Timmis, A.D. (1998) Clinical characteristics determining the mode of presentation in patients with acute coronary syndromes. J. Am. Coll. Cardiol., 32, 2018-2022.
65. Burke, A.P., Farb, A., Malcom, G.T., Liang, Y.H., Smialek, J., and Virmani, R. (1997) Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N. Engl. J. Med., 336, 1276-1282.
66. Cohen, D.J., Doucet, M., Cutlip, D.E., Ho, K.K., Popma, J.J., and Kuntz, R.E. (2001) Impact of smoking on clinical and angiographic restenosis after percutaneous coronary intervention: another smoker ' s paradox? Circulation, 104, 773-778.
67. Hasdai, D., Rihal, C.S., Lerman, A., Grill, D.E., and Holmes, D.R., Jr (1997) Smokers undergoing percutaneous coronary revascularization present with fewer narrowings in the target coronary artery. Am. J. Cardiol., 80, 1212-1214.
68. Ellamushi, H.E., Grieve, J.P., Jager, H.R., and Kitchen, N.D. (2001) Risk factors for the formation of multiple intracranial aneurysms. J. Neurosurg., 94, 728-732.
69. Krueger, J.K., and Rohrich, R.J. (2001) Clearing the smoke: the scientific rationale for tobacco abstention with plastic surgery. Plast. Reconstr. Surg., 108, 1063-1073.
70. Raveendran, M., Senthil, D., Utama, B., Shen, Y., Dudley, D., Wang, J., et al. (2004) Cigarette suppresses the expression of P4Halpha and vascular collagen production. Biochem. Biophys. Res. Commun., 323, 592-598.
71. Wilson, W.R., Herbert, K.E., Mistry, Y., Stevens, S.E., Patel, H.R., Hastings, R.A., et al. (2008) Blood leucocyte telomere DNA content predicts vascular telomere DNA content in humans with and without vascular disease. Eur. Heart J., 29, 2689-2694.
72. Vlassara, H. and Palace, M.R. (2003) Glycoxidation: the menace of diabetes and aging. Mt. Sinai J. Med., 70, 232-241.
73. Sun, L., Luo, C., Long, J., Wei, D., and Liu, J. (2006) Acrolein is a mitochondrial toxin: Effects on respiratory function and enzyme activities in isolated rat liver mitochondria. M itochondrion, 6 (3), 136-142.
74. Kapoor, D. and Jones, T.H. (2005) Smoking and hormones in health and endocrine disorders. Eur. J. Endocrinol., 152, 491-499.
75. Daniell, H.W. (1972) Osteoporosis and smoking. J AMA, 221, 509.
76. Mody, N., Parhami, F., Sarafian, T.A., and Demer, L.L. (2001) Oxidative stress modulates osteoblastic differentiation of vascular and bone cells. Free Radic. Biol. Med., 31, 509-519.
77. Sinnott, B., Syed, I., Sevrukov, A., and Barengolts, E. (2006) Coronary calcification and osteoporosis in men and postmenopausal women are independent processes associated with aging. Calcif. Tissue Int., 78, 195-202.
78. Michnovicz, J.J., Hershcopf, R.J., Naganuma, H., Bradlow, H.L., and Fishman, J. (1986) Increased 2 - hydroxylation of estradiol as a possible mechanism for the anti - estrogenic effect of cigarette smoking. N. Engl. J. Med., 315, 1305-1309.
79. Burns, D.M. (1991) Cigarettes and cigarette smoking. Clin. Chest Med., 12, 631-642.
80. Ambrose, J.A. and Barua, R.S. (2004) The pathophysiology of cigarette smoking and cardiovascular disease: an update. J. Am. Coll. Cardiol., 43, 1731-1737.
81. Ding, Y.S., Yan, X.J., Jain, R.B., Lopp, E., Tavakoli, A., Polzin, G.M., et al. (2006) Determination of 14 polycyclic aromatic hydrocarbons in mainstream smoke from U.S. brand and non - U.S. brand cigarettes. Environ. Sci. Technol., 40, 1133-1138.
82. Penn, A., Keller, K., Snyder, C., Nadas, A., and Chen, L.C. (1996) The tar fraction of cigarette smoke does not promote arteriosclerotic plaquedevelopment. Environ. Health Perspect., 104, 1108-1113.
83. Benowitz, N.L. (1999) Nicotine addiction. Prim. Care, 26, 611-631.
84. Benowitz, N.L. (1997) The role of nicotine in smoking - related cardiovascular disease. Prev. Med., 26, 412-417.
85. Gouaze, V., Dousset, N., Dousset, J.C., and Valdiguie, P. (1998) Effect of nicotine and cotinine on the susceptibility to in vitro oxidation of LDL in healthy non smokers and smokers. Clin. Chim. Acta, 277, 25-37.
86. Villablanca, A.C. (1998) Nicotine stimulates DNA synthesis and proliferation in vascular endothelial cells in vitro. J. Appl. Physiol., 84, 2089-2098.
87. Li, Z., Barrios, V., Buchholz, J.N., Glenn, T.C., and Duckles, S.P. (1994) Chronic nicotine administration does not affect peripheral vascular reactivity in the rat. J. Pharmacol. Exp. Ther., 271, 1135-1142.
88. Sun, Y.P., Zhu, B.Q., Browne, A.E., Sievers, R.E., Bekker, J.M., Chatterjee, K., et al. (2001) Nicotine does not influence arterial lipid deposits in rabbits exposed to second - hand smoke. Circulation, 104, 810-814.
89. Kjeldsen, K., Thomsen, H.K., and Astrup, P. (1974) Effects of carbon monoxide on myocardium. Ultrastructural changes in rabbits after moderate, chronic exposure. Circ. Res., 34, 339-348.
90. Kourembanas, S., Morita, T., Liu, Y., and Christou, H. (1997) Mechanisms by which oxygen regulates gene expression and cell - cell interaction in the vasculature. Kidney Int., 51, 438-443.
91. Zevin, S., Saunders, S., Gourlay, S.G., Jacob, P., and Benowitz, N.L. (2001) Cardiovascular effects of carbon monoxide and cigarette smoking. J. Am. Coll. Cardiol., 38, 1633-1638.
92. Morita, T. (2005) Heme oxygenase and atherosclerosis. Arterioscler. Thromb. Vasc. Biol., 25, 1786-1795.
93. Ndisang, J.F., Tabien, H.E., and Wang, R. (2004) Carbon monoxide and hypertension. J. Hypertens, 22, 1057-1074.
94. Stavenow, L. and Pessah - Rasmussen, H. (1988) Effects of polycyclic aromatic hydrocarbons on proliferation, collagen secretion and viability of arterial smooth muscle cells in culture. Artery, 15, 94-108.
95. Curfs, D.M., Knaapen, A.M., Pachen, D.M., Gijbels, M.J., Lutgens, E., Smook, M.L., et al. (2005) Polycyclic aromatic hydrocarbons induce an inflammatory atherosclerotic plaque phenotype irrespective of their DNA binding properties. F ASEB J., 19, 1290-1292.
96. Iwano, S., Shibahara, N., Saito, T., and Kamataki, T. (2006) Activation of p53 as a causal step for atherosclerosis induced by polycyclic aromatic hydrocarbons. FEBS Lett., 580, 890-893.
97. Belland, R.J., Ouellette, S.P., Gieffers, J., and Byrne, G.I. (2004) Chlamydia pneumoniae and atherosclerosis. Cell. Microbiol., 6, 117-127.
98. Wiedeman, J.A., Kaul, R., Heuer, L.S., Thao, N.N., Pinkerton, K.E., and Wenman, W.M. (2005) Tobacco smoke induces a persistent, but recoverable state in Chlamydia pneumoniae infection of human endothelial cells. Microb. Pathog., 39, 197-204.
99. Hasday, J.D., Bascom, R., Costa, J.J., Fitzgerald, T., and Dubin, W. (1999) Bacterial endotoxin is an active component of cigarette smoke. Chest, 115, 829-835.
100. Church, D.F. and Pryor, W.A. (1985) Free - radical chemistry of cigarette smoke and its toxicological implications. Environ. Health Perspect., 64, 111-126.
101. Pryor, W.A., Church, D.F., Evans, M.D., Rice, W.Y., Jr, and Hayes, J.R. (1990) A comparison of the free radical chemistry of tobacco - burning cigarettes and cigarettes that only heat tobacco. Free Radic. Biol. Med., 8, 275-279.
102. Kojda, G. and Harrison, D. (1999) Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure. Cardiovasc. Res., 43, 562-571.
103. Herbert, J.M., Bono, F., and Savi, P. (1996) The mitogenic effect of H2O2 for vascular smooth muscle cells ismediated by an increase of the affinity of basic fibroblast growth factor for its receptor. F EBS Lett., 395, 43-47.
104. Wang, Z., Castresana, M.R., and Newman, W.H. (2001) Reactive oxygen and NF - kappaB in VEGF - induced migration of human vascular smooth muscle cells. Biochem. Biophys. Res. Commun., 285, 669-674.
105. Messner, B. and Bernhard, D. (2010) Cadmium and cardiovascular diseases: cell biology, pathophysiology, and epidemiological relevance. Biometals, 23 (5), 811-822.
106. Bernhard, D., Rossmann, A., Henderson, B., Kind, M., Seubert, A., and Wick, G. (2006) Increased serum cadmium and strontium levels in young smokers: effects on arterial endothelial cell gene transcription. Arterioscler. Thromb. Vasc. Biol., 26, 833-838.
107. Messner, B., Knoflach, M., Seubert, A., Ritsch, A., Pfaller, K., Henderson, B., et al. (2009) Cadmium is a novel and independent risk factor for early atherosclerosis mechanisms and in vivo relevance. A rterioscler. Thromb. Vasc. Biol., 29, 1392-1398.
108. Rogalska, J., Brzoska, M.M., Roszczenko, A., and Moniuszko -Jakoniuk, J. (2009) Enhanced zinc consumption prevents cadmium -induced alterations in lipid metabolism in male rats. Chem. Biol. Interact., 177, 142-152.
109. Navas - Acien, A., Selvin, E., Sharrett, A.R., Calderon - Aranda, E., Silbergeld, E., and Guallar, E. (2004) Lead, cadmium, smoking, and increased risk of peripheral arterial disease. Circulation, 109, 3196-3201.
110. Peters, J.L., Perlstein, T.S., Perry, M.J., McNeely, E., and Weuve, J. (2010) Cadmium exposure in association with history of stroke and heart failure. Environ. Res., 110 (2), 199-206.
111. Abu - Hayyeh, S., Sian, M., Jones, K.G., Manuel, A., and Powell, J.T. (2001) Cadmium accumulation in aortas of smokers. A rterioscler. Thromb. Vasc. Biol., 21, 863-867.
112. Barry, P.S. (1975) A comparison of concentrations of lead in human tissues. Br. J. Ind. Med., 32, 119-139.
113. Kafai, M.R. and Ganji, V. (2003) Sex, age, geographical location, smoking, and alcohol consumption influence serum selenium concentrations in the USA: third National Health and Nutrition Examination Survey, 1988-1994. J. Trace Elem. Med. Biol., 17, 13-18.